Theratechnologies Inc (TSE:TH) – Stock analysts at National Bank Financial issued their FY2019 EPS estimates for shares of Theratechnologies in a research note issued on Wednesday. National Bank Financial analyst E. Leno forecasts that the company will post earnings per share of $0.43 for the year. National Bank Financial has a “Outperform” rating and a $8.75 price target on the stock.

Theratechnologies (TSE TH) opened at C$7.00 on Monday. Theratechnologies has a 1 year low of C$3.41 and a 1 year high of C$8.72. The firm has a market cap of $536.84, a PE ratio of -36.84 and a beta of 0.35.

COPYRIGHT VIOLATION NOTICE: This report was published by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at

About Theratechnologies

Theratechnologies Inc is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy.

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with's FREE daily email newsletter.